ASH Clinical Practice Guidelines on Acute Lymphoblastic Leukemia in Adolescents and Young Adults
ASH is developing new clinical practice guidelines for the treatment of adolescents and young adults with acute lymphoblastic leukemia (ALL). This project was proposed and approved by ASH members in 2019, leadership was selected in 2020, and nominations for the guideline panels were solicited in 2021.
ALL AYA Frontline Management
Dr. Wendy Stock, Chair of the ASH Acute Lymphoblastic Leukemia in Adolescents and Young Adults Frontline Management Guideline Panel from the University of Chicago, introduces ASH’s new guidelines on frontline management for adolescents and young adults with acute lymphoblastic leukemia (ALL). These recommendations are evidence-based and emphasize a collaborative, multidisciplinary approach to improving care quality and outcomes.
ALL AYA Relapsed Refractory
Dr. Kristen O’Dwyer, Chair of the ASH Acute Lymphoblastic Leukemia in Adolescents and Young Adults Relapsed/Refractory Guideline Panel from the University of Rochester Medical Center, discusses ASH’s new clinical practice guidelines focused on treating adolescents and young adults with relapsed or refractory acute lymphoblastic leukemia (ALL). These evidence-based recommendations are designed to enhance care quality through rigorous, multidisciplinary collaboration and patient-centered insights.